What is Blume?
Blume specializes in the formulation and distribution of superfood lattes and gut-health-focused beverages. The company distinguishes itself through a commitment to clean-label ingredients, low-sugar profiles, and plant-based formulations that cater to the modern, health-conscious consumer. By positioning its products as versatile rituals rather than mere commodities, Blume has cultivated a loyal community that prioritizes holistic wellness. The brand operates at the intersection of the functional food movement and the growing demand for judgment-free, inclusive health solutions, effectively bridging the gap between traditional dietary supplements and everyday beverage consumption.
How much funding has Blume raised?
Blume has raised a total of $30K across 1 funding round:
Stock/Share Issuance
$30K
Stock/Share Issuance (2026): $30K, investors not publicly disclosed
Key Investors in Blume
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Blume?
With the infusion of this recent financing, Blume is expected to prioritize operational scaling and supply chain optimization to meet rising consumer demand. The strategic roadmap likely includes expanding its retail distribution network across North America and investing in product innovation to diversify its gut-health portfolio. As the company navigates this significant Series B/C stage, the focus will shift toward achieving sustainable profitability while maintaining the brand integrity that has defined its early growth. Investors will be closely monitoring the company's ability to maintain its premium market position while scaling its manufacturing capabilities to support broader market reach.
See full Blume company page
